Main Article Content

S. O. Okoh
E. E. Bassey
V. M. Agah
C. A. Nwambe
S. O. Azi
B. C. Nweke
P. N. Okorie
L. I. Uwanta


Candidiasis has been identified as a ubiquitous fungal infection commonly affecting people living with HIV/AIDS. This research ascertained the prevalence and risk factors forral and vaginal candidiasis among 180 HIV out-patients at Ebonyi State General Hospital, Ezzangbo. Oral and vaginal swabs were aseptically collected from the participants in duplicate. One of the swabs was streaked on Sabouraud's Dextrose Agar (SDA) and isolates were identified using macroscopic characteristics while the second swab was used for microscopic examination. Structured questionnaires were administered to participants to obtain risk factors associated with the infections. The antifungal susceptibility testing of the Candida isolates was performed using disc diffusion method. Data obtained was statistically analysed using Statistical Package for Social Scientist (SPSS). Results obtained from the study indicated 120(66.7%) were positive for Candidiasis; 31.7% was positive for only vaginal Candidiasis, 22.2% were positive for only oral Candidiasis while 12.8% had both. Candida albicans (CA) was dominant with 71% while none albicans Candida (NAC) was 29%. Isolates were most sensitive to Itraconazole and Griseofluvin and less sensitive to Ketoconazole, Nystatin and Fluconazole. The results of this study underlined essentials of good hygiene practices and importance of regularly assessing HIV patients for candidiasis.

Article Details

How to Cite
Okoh, S. O., Bassey, E. E., Agah, V. M., Nwambe, C. A., Azi, S. O., Nweke, B. C., Okorie, P. N., & Uwanta, L. I. (2023). CANDIDIA AND HIV CO-INFECTIONS AMONG WOMEN ATTENDING HIV CLINIC AT GENERAL HOSPITAL EZZANGBO, NIGERIA. The Bioscientist Journal, 11(3), 256-269.


Adam, F. (2018). “Explaining HIV and AIDS”. Medical News Today. Accessed 4th May 2022.
Bauer, A.W., Kirby, W.M.M, Sherris, J.C., Turck, M. (1966). Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology,45:493-496.
Campisi G, Pizzo G, Milici M. E, Mancuso S, Margiotta V. (2002). Candida carriage in the oral cavity of human immunodeficiency virus infected subjects. Oral Surg Oral Med Oral Pathology, 93:281–286.
CDC. (2018) HIV/AIDS: HIV treatment. Center for Disease Control and Prevention. Accessed 3rd May 2022.
Charan J, Biswas T. (2013). How to calculate sample size for different study designs in medical research. Indian. Journal of Psychological Medicine,35:121-126.
Cheesbrough, M. (2006). Antimicrobial Susceptibility Testing In: Cheesbrough. M (ed). District laboratory practice in Tropical Countries, Part 2 Cambridge University Press Cape Town, South Africa. pp. 132-142.
EBMOI (2014). Diary: A Publication of Ebonyi State Ministry of Information, Abakaliki Ebonyi State, Nigeria. Pp.10-15.
Enitan. S.S., John, C.I., Abiodun, O., Ochei, J.O., Etodo, G.E. and Aluko, J.O. (2019). Candidia in HIV positive female Adults on HAART in Ogun State Nigeria: Prevalence, Risk Factors and Antifungal susceptibility Study.ARC Journal of AIDS,4(2):1-17
Esebelahie, N.O., Enweani, I.B. and Omoregie, R. (2013). Candida colonization in asymptomatic HIV patient attending a tertiary hospital in Benin City, Nigeria. Libyan Journal of Medicine,8(1):1-5.
Goulart, L.S., Souza, W.W., Vieira, C.A., Lima, J.S., Olinda, R.A. and Araújo, C. (2018). Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study. Einstein (SãoPaulo), 16(3):4-224.
Gugnani, H.C., Becker, K., Fegeler, W., Basu, S., Chattopadhya, D., Baveja, U., Satyanarayana, S., Kalghatgi, T. and Murlidhar, A. (2003). Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses, 46:299–306.
Hamza, O.J., Matee, M.N., Moshi, M.J., Simon, E.M., Mugusi, F., Mikx, F.M., Helderman, W.P., Rijs, A.J., VanderVen, A.J. and Verweij, P.E. (2018). Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiology,8:135-144.
Kwamin F, Nartey N.O, Codjoe F, Newman M.J. (2013). Distribution of Candida species among HIV positive patients with oropharyngeal candidiasis in Accra, Ghana. Journal of Infection in Developing Countries, 7(1):041-045.
Lar, P.M., Pam, K.V., Tiri, Y., Olukose, S., Yusuf, A., Dashen, M.M. and Mawak, J.D. (2012). Prevalence and distribution of Candida Species in HIV infected persons on antiretroviral therapy in Jos. Journal of Medicine and Medical Science,3(4):254-259.
Li, Y.Y., Chen, W.Y., LiX, LiH. B. and Wang Land HeL. (2013). A symptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infectious Disease, 13:46.
Lin, J.N., Lin, C.C., Lai, C.H., Yang, Y.L., Chen, H.T. and Weng, H.C. (2013). Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus infected patients: a prospective cross-sectional study. Journal of Microbiology Immunological Infection,46(2):129-135.
Monika, M., Ravinder, K. and Sanjim, C. (2016). Candida species prevalence profile in HIV seropositive patients from a major tertiary care hospital in New Delhi, India. Journal of pathogens Accessed 18th July, 2022.
NACA (2020) Nigeria HIV Prevalence Rate. National Agency for the Control of AIDS, Nigeria. www.https// 7th July, 2022.
Naga R A, Anil K. K, Giridhar V, Santi V. (2019) Prevalence of oral candidiasis in HIV infected children treated with antiretroviral drugs. International Journal of Stomatology and Occlusion Medicine,6(4):130-133.
Njunda, A.L., Nsagha, D.S., Assob, J.C., Kamga., H.L. and Teyim, P. (2011). Candidiasis in HIV and AIDS Patients Attending the Nylon Health District Hospital in Douala, Cameroon. TAF Prev Med Bulletin, 10(6):701-706.
NPC (2006). Report of Nigeria’s National Population Commission on the 2006 census. Population and Development review, 33: 206-210.
Ochei, J. and Kolhatkar, A. (2007). Diagnosis of Infections by Specific Anatomic Site (Chapter 9) In: Ochei, J. and Kolhatkar, A. (Eds.). Theory and practice of medical laboratory science. Tata McGraw-Hill publishing Company Limited, New Delhi, India. Pp. 1057-1107.
Okonkwo E.C, Alo M.N, Nworie O, Orji J.O, Agah M.V. (2013). Prevalence of Oral Candida albicans Infection in HIV Sero-Positive Patients in Abakaliki. American Journal of Life Science,1(2):72-76.
Paula, S.B., Morey, A.T., Santos, J.P., Santos, P.M., Gameiro, D.G. and Kerbauy, G. (2015). Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors. Journal of Infections in Developing Countries. 9(12):1350-1359.
Pongsiriwet, S., Iamaroon, A., Sriburee, P., Pattanaporn, K. and Krisanaprakornkit, S. (2004). Oral colonization of Candida species in perinatally HIV infected children in northern Thailand. Journal of Oral Science, 46:101–105.
Schuman, P., Ohmit, S.E. and Sobel, J.D. (1998). Oral lesions in women living with oral risk for HIV infection. American Journal of Medicine, 104:559–564.
Smith, C.J, Sabin, C.A. and Lampe, F.C. (2018). The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy. AIDS, 17(7):963-969.
Spalanzani, R.N., Mattos, K., Marques, L.I., Barros, P.F.D., Pereira, P.I.P., Paniago, A.M.M., Mendes, R.P. and Chang, M.R. (2018). Clinical and laboratorial features of oral candidiasis in HIV- positive patients. Rev Soc Bras Med Trop.,51(3):352-356.
Tsang, C.S. and Samaranayake, L.P. (2000). Oralyeasts and coliforms in HIV infected individuals in Hong Kong. Mycoses,.43:303–308.
Umeh, E.U. and Umeakanne, B.I. (2010). HIV/ Vaginal candida co-infection: Risk factors in women. Journal of Microbiology and Antimicrobials,2(3):30-35.
UNAIDS (2019) Global HIV & AIDS Statistics: HIV and AIDS in Nigeria. Fact Sheet. Accessed 7th July, 2022.
Vijeta, M. A., Shutosh, S., Jyoti, M. and Vimla, V. (2013). Oropharyngeal candidiasis and candida colonisation in HIV positive patients in Northern India. The Journal of Infections in Developing Countries.7(8):608-613.